Cellomics raises $5.3 million

Jan. 12, 2004 — Cellomics Inc., a Pittsburgh-based producer of tools for high-content screening, announced a $5.3 million sixth round of equity financing.

null

Investors include existing investors Carl Zeiss MicroImaging Inc., Oxford Bioscience Partners, Vector Fund Management, InterWest Partners, Alta California Partners, Burrill Biotechnology and Axiom Venture Partners. CK Capital also participated.

null

Cellomics collaborated with Zeiss in 2003 to design and manufacture the ArrayScan VTI, which was launched in the fourth quarter.

POST A COMMENT

Easily post a comment below using your Linkedin, Twitter, Google or Facebook account. Comments won't automatically be posted to your social media accounts unless you select to share.